Episodes

Dr Regine Mydlarski joins Kirk Barber, Editor in Chief of the Journal of Cutaneous Medicine, for a fascinating snapshot of what Canadian Dermatology looks like today and what changes need to be made to meet the evolving needs of patients across Canada. As Chair of the Dermatology Working Group at the Royal College of Physicians and Surgeons of Canada, Dr Mydlarski led a comprehensive and objective analysis of the state of dermatology in Canada. This resulted in two articles in the JCMS, one in 2...

"They want to live without the fear of discrimination due to the appearance of their skin. In the context of June 2020 and Black Lives Matter and racism, this seems to be a very timely thing the patients have brought up." Dr Harvey Lui is JCMS Editor-in-Chief Dr Kirk Barber's guest on this edition of JCMS Author Interviews. They discuss Dr Lui's article, "Developing a Patient Charter for People Living With Conditions, Diseases, or Traumas Involving the Skin" in the March/April edition of the Jo...

"They want to live without the fear of discrimination due to the appearance of their skin. In the context of June 2020 and Black Lives Matter and racism, this seems to be a very timely thing the patients have brought up." Dr Harvey Lui is JCMS Editor-in-Chief Dr Kirk Barber's guest on this edition of JCMS Author Interviews. They discuss Dr Lui's article, "Developing a Patient Charter for People Living With Conditions, Diseases, or Traumas Involving the Skin" in the March/April edition of the Jo...

"They want to live without the fear of discrimination due to the appearance of their skin. In the context of June 2020 and Black Lives Matter and racism, this seems to be a very timely thing the patients have brought up." Dr Harvey Lui is JCMS Editor-in-Chief Dr Kirk Barber's guest on this edition of JCMS Author Interviews. They discuss Dr Lui's article, "Developing a Patient Charter for People Living With Conditions, Diseases, or Traumas Involving the Skin" in the March/April edition of the Jo...

Dr Steven Feldman is JCMS Editor-in-Chief Dr Kirk Barber's guest on this latest edition of JCMS Author Interviews. The two have an in-depth conversation about the importance of empathy, or the appearance of empathy by doctors, as a means of getting patients to do a better job of treating themselves or their families. This conversation is based on the Article “Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers’ Willingness to use Corticosteroids: A Randomized Controlled t...

Dr Steven Feldman is JCMS Editor-in-Chief Dr Kirk Barber's guest on this latest edition of JCMS Author Interviews. The two have an in-depth conversation about the importance of empathy, or the appearance of empathy by doctors, as a means of getting patients to do a better job of treating themselves or their families. This conversation is based on the Article “Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers’ Willingness to use Corticosteroids: A Randomized Controlled t...

Dr Steven Feldman is JCMS Editor-in-Chief Dr Kirk Barber's guest on this latest edition of JCMS Author Interviews. The two have an in-depth conversation about the importance of empathy, or the appearance of empathy by doctors, as a means of getting patients to do a better job of treating themselves or their families. This conversation is based on the Article “Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers’ Willingness to use Corticosteroids: A Randomized Controlled t...

Dr. Kirk Barber interviews Dr. Aaron Drucker, one of the authors of "Canadian burden of skin disease from 1990 to 2017: Results from the Global Burden of Disease 2017 study," in the March-April edition of the Journal of Cutaneous Medicine and Surgery. Kirk and Aaron discuss some of the most important discoveries in the data found in the study and why it is a treasure trove for research and for putting together grant proposals. Accurate and up-to-date data on disease burden at the population lev...

Dr. Kirk Barber interviews Dr. Aaron Drucker, one of the authors of "Canadian burden of skin disease from 1990 to 2017: Results from the Global Burden of Disease 2017 study," in the March-April edition of the Journal of Cutaneous Medicine and Surgery. Kirk and Aaron discuss some of the most important discoveries in the data found in the study and why it is a treasure trove for research and for putting together grant proposals. Accurate and up-to-date data on disease burden at the population lev...

Dr. Kirk Barber interviews Dr. Aaron Drucker, one of the authors of "Canadian burden of skin disease from 1990 to 2017: Results from the Global Burden of Disease 2017 study," in the March-April edition of the Journal of Cutaneous Medicine and Surgery. Kirk and Aaron discuss some of the most important discoveries in the data found in the study and why it is a treasure trove for research and for putting together grant proposals. Accurate and up-to-date data on disease burden at the population lev...

Dr. Catherine Besner-Morin talks with JCMS editor-in-chief Dr. Kirk Barber about the article on treating itch that she co-authored in the September-October 2019 issue of the Journal of Cutaneous Medicine and Surgery. Itch treatment is a major challenge in the dermatologist’s practice. We encounter patients suffering from pruritus on a regular basis, and often lack diverse treatment options to adequately respond to the patients’ needs. Dr. Besner-Morin discusses the novel pathways have been inves...

Dr. Catherine Besner-Morin talks with JCMS editor-in-chief Dr. Kirk Barber about the article on treating itch that she co-authored in the September-October 2019 issue of the Journal of Cutaneous Medicine and Surgery. Itch treatment is a major challenge in the dermatologist’s practice. We encounter patients suffering from pruritus on a regular basis, and often lack diverse treatment options to adequately respond to the patients’ needs. Dr. Besner-Morin discusses the novel pathways have been inves...

Dr. Catherine Besner-Morin talks with JCMS editor-in-chief Dr. Kirk Barber about the article on treating itch that she co-authored in the September-October 2019 issue of the Journal of Cutaneous Medicine and Surgery. Itch treatment is a major challenge in the dermatologist’s practice. We encounter patients suffering from pruritus on a regular basis, and often lack diverse treatment options to adequately respond to the patients’ needs. Dr. Besner-Morin discusses the novel pathways have been inves...

Dr. Michele Ramien talks with JCMS editor-in-chief Dr. Kirk Barber about the article she co-authored in the Nov-Dec 2019 issue of the Journal of Cutaneous Medicine and Surgery. In their conversation, Michele describes to Kirk the potential efficacy of cyclosporine A in the treatment of Mycoplasma pneumoniae-induced rash and mucositis, also known as MIRM. MIRM is a relatively newly recognized clinical entity that typically presents with predominant mucositis accompanied by variable cutaneous invo...

Dr. Michele Ramien talks with JCMS editor-in-chief Dr. Kirk Barber about the article she co-authored in the Nov-Dec 2019 issue of the Journal of Cutaneous Medicine and Surgery. In their conversation, Michele describes to Kirk the potential efficacy of cyclosporine A in the treatment of Mycoplasma pneumoniae-induced rash and mucositis, also known as MIRM. MIRM is a relatively newly recognized clinical entity that typically presents with predominant mucositis accompanied by variable cutaneous invo...

Dr. Michele Ramien talks with JCMS editor-in-chief Dr. Kirk Barber about the article she co-authored in the Nov-Dec 2019 issue of the Journal of Cutaneous Medicine and Surgery. In their conversation, Michele describes to Kirk the potential efficacy of cyclosporine A in the treatment of Mycoplasma pneumoniae-induced rash and mucositis, also known as MIRM. MIRM is a relatively newly recognized clinical entity that typically presents with predominant mucositis accompanied by variable cutaneous invo...

Dr. Robert Gniadecki speaks with JCMS Editor-in-chief, Dr. Kirk Barber, about the article Gniadecki co-authored in the Sept/Oct 2019 edition of the Journal of Cutaneous Medicine and Surgery. They discuss two progressive primary cutaneous T-cell lymphomas for which there are no curative treatments, Mycosis fungoides and Sézary syndrome. Dr Gniadecki explains why Immunotherapy seems to be a promising avenue to achieve long-term disease control in CTCL, with compelling evidence indicating that Myco...

Dr. Robert Gniadecki speaks with JCMS Editor-in-chief, Dr. Kirk Barber, about the article Gniadecki co-authored in the Sept/Oct 2019 edition of the Journal of Cutaneous Medicine and Surgery. They discuss two progressive primary cutaneous T-cell lymphomas for which there are no curative treatments, Mycosis fungoides and Sézary syndrome. Dr Gniadecki explains why Immunotherapy seems to be a promising avenue to achieve long-term disease control in CTCL, with compelling evidence indicating that Myco...

Dr. Robert Gniadecki speaks with JCMS Editor-in-chief, Dr. Kirk Barber, about the article Gniadecki co-authored in the Sept/Oct 2019 edition of the Journal of Cutaneous Medicine and Surgery. They discuss two progressive primary cutaneous T-cell lymphomas for which there are no curative treatments, Mycosis fungoides and Sézary syndrome. Dr Gniadecki explains why Immunotherapy seems to be a promising avenue to achieve long-term disease control in CTCL, with compelling evidence indicating that Myco...

Dr. Jan Dutz speaks with JCMS Editor-in-chief Dr Kirk Barber about the article Dutz co-authored in the Nov/Dec 2019 edition of the Journal of Cutaneous Medicine and Surgery. The article focuses on how East Asians exposed to the urate-lowering drug allopurinol have a predilection for severe cutaneous drug reactions such as drug-induced hypersensitivity syndrome or drug reaction with eosinophilia and systemic symptoms and Stevens-Johnson syndrome/toxic epidermal necrolysis. Dr Barber and Dr Dutz d...

Dr. Jan Dutz speaks with JCMS Editor-in-chief Dr Kirk Barber about the article Dutz co-authored in the Nov/Dec 2019 edition of the Journal of Cutaneous Medicine and Surgery. The article focuses on how East Asians exposed to the urate-lowering drug allopurinol have a predilection for severe cutaneous drug reactions such as drug-induced hypersensitivity syndrome or drug reaction with eosinophilia and systemic symptoms and Stevens-Johnson syndrome/toxic epidermal necrolysis. Dr Barber and Dr Dutz d...

Dr. Jan Dutz speaks with JCMS Editor-in-chief Dr Kirk Barber about the article Dutz co-authored in the Nov/Dec 2019 edition of the Journal of Cutaneous Medicine and Surgery. The article focuses on how East Asians exposed to the urate-lowering drug allopurinol have a predilection for severe cutaneous drug reactions such as drug-induced hypersensitivity syndrome or drug reaction with eosinophilia and systemic symptoms and Stevens-Johnson syndrome/toxic epidermal necrolysis. Dr Barber and Dr Dutz d...

Dr Melinda Gooderham speaks with JCMS Editor-in-chief Dr Kirk Barber about her literature review in the May/June 2019 edition of JCMS. Dr Gooderham and her co-author Nicole Relke looked at vitiligo pathophysiology, reviewed current therapy and discussed the potential value of JAK inhibitors. Their literature review shows JAK inhibitors in patients with vitiligo have a favorable safety profile and effectively produce repigmentation of lesions, especially with concomitant ultraviolet exposure. Dr...

Dr Melinda Gooderham speaks with JCMS Editor-in-chief Dr Kirk Barber about her literature review in the May/June 2019 edition of JCMS. Dr Gooderham and her co-author Nicole Relke looked at vitiligo pathophysiology, reviewed current therapy and discussed the potential value of JAK inhibitors. Their literature review shows JAK inhibitors in patients with vitiligo have a favorable safety profile and effectively produce repigmentation of lesions, especially with concomitant ultraviolet exposure. Dr...